{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:20:23Z","timestamp":1793931623038,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI124413-01"],"award-info":[{"award-number":["R01AI124413-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3080-2","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T13:23:14Z","timestamp":1523452994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB\/HIV co-infected patients in KwaZulu-Natal, South Africa"],"prefix":"10.1186","volume":"18","author":[{"given":"N.","family":"Bionghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Daftary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Msibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. R.","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Orrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Padayatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"3080_CR1","volume-title":"Global Tuberculosis Report, 2015","author":"Organization WHO","year":"2016","unstructured":"Organization WHO. Global Tuberculosis Report, 2015. Geneva: World Health Organization; 2016."},{"key":"3080_CR2","unstructured":"(World Health Organization) WHO. Multidrug-resistant tuberculosis (MDR-TB). In: Multidrug-resistant tuberculosis (MDR-TB): 2016 update. Geneva: World Health Organization; 2016."},{"key":"3080_CR3","volume-title":"Global tuberculosis report, 2016","author":"Organization WHO","year":"2016","unstructured":"Organization WHO. Global tuberculosis report, 2016. Geneva: World Health Organization; 2016."},{"issue":"1","key":"3080_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5588\/ijtld.11.0153","volume":"16","author":"NR Gandhi","year":"2012","unstructured":"Gandhi NR, Andrews JR, Brust J, Montreuil R, Weissman D, Heo M, Moll A, Friedland G, Shah N. Risk factors for mortality among MDR-and XDR-TB patients in a high HIV prevalence setting. The International Journal of Tuberculosis and Lung Disease. 2012;16(1):90\u20137.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"3","key":"3080_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3201\/eid1903.120998","volume":"19","author":"MR O\u2019Donnell","year":"2013","unstructured":"O\u2019Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis. 2013;19(3):416.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"3080_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0002-9343(96)00402-0","volume":"102","author":"A Pablos-M\u00e9ndez","year":"1997","unstructured":"Pablos-M\u00e9ndez A, Knirsch CA, Graham Barr R, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102(2):164\u201370.","journal-title":"Am J Med"},{"issue":"2","key":"3080_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ccm.2005.02.001","volume":"26","author":"TR Frieden","year":"2005","unstructured":"Frieden TR, Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clin Chest Med. 2005;26(2):197\u2013205.","journal-title":"Clin Chest Med"},{"key":"3080_CR8","doi-asserted-by":"publisher","unstructured":"M'Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. The Cochrane Library; 2012;(5). Article no. CD006591. \n                    https:\/\/doi.org\/10.1002\/14651858.CD006591.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD006591.pub2"},{"issue":"4","key":"3080_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11904-005-0017-3","volume":"2","author":"T Kerr","year":"2005","unstructured":"Kerr T, Walsh J, Lloyd-Smith E, Wood E. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Current HIV\/AIDS Reports. 2005;2(4):200\u20135.","journal-title":"Current HIV\/AIDS Reports"},{"issue":"1","key":"3080_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","volume":"17","author":"AB Williams","year":"2013","unstructured":"Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2013;17(1):284\u201397.","journal-title":"AIDS Behav"},{"issue":"1","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7326\/0003-4819-152-1-201001050-00012","volume":"152","author":"DR Bangsberg","year":"2010","unstructured":"Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152(1):54\u20136.","journal-title":"Ann Intern Med"},{"issue":"4","key":"3080_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5588\/ijtld.15.0360","volume":"20","author":"MR O'Donnell","year":"2016","unstructured":"O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico K, Senthilingam M, Wolf A, Metcalfe J, Isaakidis P, Davis J. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. The International Journal of Tuberculosis and Lung Disease. 2016;20(4):430\u20134.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"8","key":"3080_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1313865","volume":"371","author":"AH Diacon","year":"2014","unstructured":"Diacon AH, Pym A, Grobusch MP, de Los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med. 2014;371(8):723\u201332.","journal-title":"N Engl J Med"},{"issue":"20","key":"3080_CR14","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMc1505196","volume":"373","author":"GV Bloemberg","year":"2015","unstructured":"Bloemberg GV, Keller PM, Stucki D, Trauner A, Borrell S, Latshang T, Coscolla M, Rothe T, H\u00f6mke R, Ritter C. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis. N Engl J Med. 2015;373(20):1986\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"3080_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","unstructured":"Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nursing & health sciences. 2013;15(3):398\u2013405.","journal-title":"Nursing & health sciences"},{"issue":"5","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/QAI.0000000000000770","volume":"70","author":"C Orrell","year":"2015","unstructured":"Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2015;70(5):495\u2013502.","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"3080_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s10461-010-9799-4","volume":"14","author":"JE Haberer","year":"2010","unstructured":"Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, Bangsberg DR. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340\u20136.","journal-title":"AIDS Behav"},{"key":"3080_CR18","doi-asserted-by":"crossref","unstructured":"Haberer JE, Kiwanuka J, Nansera D, Muzoora C, Hunt PW, So J, O'donnell M, Siedner M, Martin JN, Bangsberg DR. Real-time adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS (London, England). 2013;27(13):2166-8.","DOI":"10.1097\/QAD.0b013e328363b53f"},{"issue":"2","key":"3080_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10461-011-9933-y","volume":"16","author":"JE Haberer","year":"2012","unstructured":"Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, Johnson MO, Bangsberg DR. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16(2):375\u201382.","journal-title":"AIDS Behav"},{"issue":"12","key":"3080_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00228-007-0369-2","volume":"63","author":"R Vriesendorp","year":"2007","unstructured":"Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol. 2007;63(12):1115\u201321.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3080_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/QAI.0000000000000221","volume":"67","author":"MR O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study. Journal of acquired immune deficiency syndromes (1999). 2014;67(1):22.","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"9","key":"3080_CR22","doi-asserted-by":"publisher","first-page":"e1001876","DOI":"10.1371\/journal.pmed.1001876","volume":"12","author":"X Liu","year":"2015","unstructured":"Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, Bai L, Li J, Li X, Chen H. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9):e1001876.","journal-title":"PLoS Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3080-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3080-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:28:31Z","timestamp":1589455711000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3080-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3080-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"assertion":[{"value":"31 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards at Columbia University Medical Center and the Biomedical Research Ethics Committee at the University of KwaZulu-Natal in South Africa. Written informed consent was obtained from all patients in either isiZulu or English.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"171"}}